Skip to main content
CTOS 2023 Main banner
Final Program


Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Paul Meyers, MD (he/him/his)

Vice Chair Department of Pediatrics
Memorial Sloan Kettering Cancer Center
New York City, New York, United States

Dr. Paul Meyers is Vice Chair of the Department of Pediatrics and Chair of the Sarcoma Service in the Department of Pediatrics at the Memorial Sloan-Kettering Cancer Center and Professor of Pediatrics at the Weill Cornell Medical College. He received his undergraduate degree from Brown University and his MD from the Mount Sinai School of Medicine. He trained in pediatrics at the Mount Sinai Hospital. He trained in pediatric hematology/oncology at the Cornell University Medical College and the Memorial Sloan-Kettering Cancer Center. Since 1979 he has been member of the faculty at the Memorial Sloan-Kettering Cancer Center. He has treated or consulted on over 5000 children and young adults. In 1995 he was the recipient of the Willett Whitmore Award for Clinical Excellence. He served as the vice chair and chair of the Bone Sarcoma Strategy Group for the Children’s Oncology Group from 1991-2001. He has been a member of the Pediatric Board of the National Cancer Institute Physician Data Query since 2001. He served on Subcommittee H of the National Cancer Institute from 2006-2009. He served as president of the Connective Tissue Oncology Society in 2008. His research has focused on treatments for sarcomas of children and young adults. He was the principal investigator of national clinical trials in osteosarcoma and Ewing sarcoma conducted by the pediatric cooperative groups and clinical trials at the Memorial Sloan-Kettering Cancer Center. He was the principal investigator of a clinical trial for the treatment of osteosarcoma which led to the approval of muramyl tripeptide for the treatment of children and young adults with osteosarcoma in 45 countries. He has authored or co-authored over 200 articles in the peer reviewed medical literature.

Disclosure information not submitted.

Presentation(s):

Email Paul